Akos Czibere
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
Akos Czibere currently works at Aktis Oncology, Inc., as Chief Medical Officer from 2024.
Dr. Czibere also formerly worked at Merrimack Pharmaceuticals, Inc., as Vice President-Clinical Development and Pfizer Inc., as Vice President-Therapeutic Area.
Dr. Czibere received his doctorate degree from Heinrich-Heine-Universität Düsseldorf.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AKTIS ONCOLOGY, INC. -.--% | 23.09.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Heinrich-Heine-Universität Düsseldorf
Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aktis Oncology, Inc.
Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen